ABSTRACT 

Background. Global surgery indicators measure a country’s capacity, not what happens to a patient between the first symptoms and discharge. Intracranial suppurations (ICS) test every link in the chain of care. We used them as a tracer condition to build and test a framework for measuring quality in neurosurgery. Methods. Single-center cohort study, retrospective then prospective, of 150 observations (148 patients) of ICS managed at Bouaké University Hospital (Côte d’Ivoire) from 2016 to 2026. This is a secondary analysis of a cohort whose main study is the subject of a separate manuscript. The ISQF framework comprises twenty indicators distributed according to the Donabedian model: six of structure, eight of process, and six of outcomes. A composite compliance score (ISI-QI) was calculated for each patient. Two Firth penalized logistic regression models (in-hospital mortality; unfavorable outcome, GOS 1–3) combined the ISI-QI, a Glasgow Coma Scale (GCS) score below 9, and an age of at least 65 years. Internal validation relied on 2,000 bootstrap samples with optimism correction. No protocol was registered. The report follows STROBE, SQUIRE 2.0, and TRIPOD+AI; no machine learning method was used. Results. Overall process compliance was 89.0% (878/987 care opportunities; 95% CI: 86.9–90.8). Clinical indicators met or approached their targets. Timeliness indicators fell short: 67.0% of patients with a surgical indication were operated on within 48 hours, and 2.0% were admitted within seven days of symptom onset. The median delay to surgery was 20 days, of which about 95% elapsed before reaching the hospital. Only 34 of 150 patients (22.7%) received antibiotic therapy guided by the antibiogram. The ISI-QI was not associated with mortality (aOR 1.18 per 10-point increment; 95% CI: 0.72–2.06) but was associated with unfavorable outcome (aOR 1.52; 1.04–2.29), solely because of the early-surgery indicator (aOR 3.72; 1.31–11.41): patients operated on early were more severe (GCS < 9 in 18.2% of cases versus 2.6%). Without this indicator, the association disappeared (aOR 1.15; 0.80–1.69). After optimism correction, the ISI-QI added nothing to initial severity for mortality (C statistic 0.646 versus 0.651), and for functional outcome the apparent gain (0.676 to 0.739) disappeared without the early-surgery indicator (0.685). Conclusion. ICS lend themselves to quality measurement from ordinary records. The failure lies before the hospital and in the microbiological chain, not in the operating room. The ISI-QI describes the compliance of an organization; it does not predict the outcome of a patient. From this we derive a ten-indicator dashboard, the ISI-QI-10. Level of evidence. III. Protocol registration. None (secondary analysis of an observational cohort).

KEYWORDS

quality of care; tracer condition; Donabedian model; intracranial suppuration; brain abscess; global neurosurgery; sub-Saharan Africa; performance indicators; confounding by indication

REFERENCES

1) Kruk ME, Gage AD, Arsenault C, Jordan K, Leslie HH, Roder-DeWan S, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet Glob Health. 2018;6(11):e1196-e1252.
2) Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386(9993):569-624.
3) Dewan MC, Rattani A, Fieggen G, Arráez MA, Servadei F, Boop FA, et al. Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. J Neurosurg. 2018;130(4):1055-1064.
4) Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3 Suppl):166-206.
5) Donabedian A. The quality of care: how can it be assessed? JAMA. 1988;260(12):1743-1748.
6) Lilford R, Mohammed MA, Spiegelhalter D, Thomson R. Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma. Lancet. 2004;363(9415):1147-1154.
7) Iezzoni LI. The risks of risk adjustment. JAMA. 1997;278(19):1600-1607.
8) Kessner DM, Kalk CE, Singer J. Assessing health quality: the case for tracers. N Engl J Med. 1973;288(4):189-194.
9) NIHR Global Health Research Unit on Global Surgery. Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries. Lancet Glob Health. 2024;12(7):e1094-e1103.
10) Brouwer MC, Tunkel AR, McKhann GM II, van de Beek D. Brain abscess. N Engl J Med. 2014;371(5):447-456.
11) Bodilsen J, D’Alessandris QG, Humphreys H, Iro MA, Klein M, Last K, et al. European Society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect. 2024;30(1):66-89.
12) Nathoo N, Nadvi SS, van Dellen JR. Taming an old enemy: a profile of intracranial suppuration. World Neurosurg. 2012;77(3-4):484-490.
13) Djientcheu VP, Mouafo Tambo FF, Esiene A, Nguefack S, Mewa Kinoo S, Bello F, et al. Intracranial suppurations in the African child: a severe but preventable condition. Childs Nerv Syst. 2013;29(1):119-123.
14) Chikani MC, Mezue WC, Ohaegbulam SC, Ndubuisi CA, Chikani UN. Subdural empyema: clinical presentations and management options for an uncommon neurosurgical emergency in a developing country. Niger J Clin Pract. 2017;20(10):1221-1225.
15) Jolayemi EO, Olaniyi EO, Shokunbi MT, Malomo AO. Contemporary management of intracranial subdural empyema: an institutional experience. J West Afr Coll Surg. 2022;12(4):31-38.
16) Boukassa L, Ngackosso OB, Kinata SB, Ekouele Mbaki HB. Intracranial suppurations in Africa: systematic review. Open J Mod Neurosurg. 2020;10(2):244-253.
17) Ooi SZY, Sichimba D, Dalle DU, Higginbotham G, Takoutsing BD, Bankole NDA, et al. Management and outcomes of paediatric intracranial suppurations in low- and middle-income countries: a scoping review. Front Surg. 2021;8:690895.
18) Nathoo N, Nadvi SS, Narotam PK, van Dellen JR. Brain abscess: management and outcome analysis of a computed tomography era experience with 973 patients. World Neurosurg. 2011;75(5-6):716-726.
19) Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med. 2019;170(1):W1-W33.
20) Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.
21) von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
22) Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0: revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25(12):986-992.
23) Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014;82(9):806-813.
24) Bodilsen J, Duerlund LS, Mariager T, Brandt CT, Petersen PT, Larsen L, et al. Clinical features and prognostic factors in adults with brain abscess. Brain. 2023;146(4):1637-1647.
25) Tseng JH, Tseng MY. Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol. 2006;65(6):557-562.
26) Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15(6):523-530.
27) Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003;326(7393):816-819.
28) Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. JAMA. 2006;295(10):1168-1170.
29) Little RJA, Rubin DB. Statistical analysis with missing data. 3rd ed. Hoboken: Wiley; 2019.
30) Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
31) Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80(1):27-38.
32) Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409-2419.
33) Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, et al. Minimum sample size for developing a multivariable prediction model: Part II — binary and time-to-event outcomes. Stat Med. 2019;38(7):1276-1296.
34) Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774-781.
35) Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387.
36) Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-138.
37) Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230.
38) Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565-574.
39) Vickers AJ, van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ. 2016;352:i6.
40) Thaddeus S, Maine D. Too far to walk: maternal mortality in context. Soc Sci Med. 1994;38(8):1091-1110.
41) Nguembu S, Kanmounye US, Tétinou F, Djiofack D, Takoukam R. Barriers to management of nontraumatic neurosurgical diseases at 2 Cameroonian neurosurgical centers: cross-sectional study. World Neurosurg. 2020;139:e774-e783.
42) Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793-800.
43) Al Masalma M, Lonjon M, Richet H, Dufour H, Roche PH, Drancourt M, et al. Metagenomic analysis of brain abscesses identifies specific bacterial associations. Clin Infect Dis. 2012;54(2):202-210.
44) Cobo F, Rodríguez-Granger J, Sampedro A, Aliaga-Martínez L, Navarro-Marí JM. Brain abscesses caused by anaerobic microorganisms: a systematic review. Anaerobe. 2023;79:102668.
45) Kommedal Ø, Wilhelmsen MT, Skrede S, Meisal R, Jakovljev A, Gaustad P, et al. Massive parallel sequencing provides new perspectives on bacterial brain abscesses. J Clin Microbiol. 2014;52(6):1990-1997.
46) John DV, Ramakrishnan R, Thomas B, Nair S, Abraham OC. Identification of microbial agents in culture-negative brain abscess samples by 16S/18S ribosomal RNA gene PCR and sequencing. J Clin Microbiol. 2023;61(1):e01254-22.
47) Wang X, Guo X, Liu H, Wang B, Wu J, Chen S, et al. Augmented pathogen detection in brain abscess using metagenomic next-generation sequencing: a retrospective cohort study. Microbiol Spectr. 2024;12(10):e0032524.
48) Walker AM. Confounding by indication. Epidemiology. 1996;7(4):335-336.
49) Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. JAMA. 2016;316(17):1818-1819.
50) Alkire BC, Raykar NP, Shrime MG, Weiser TG, Bickler SW, Rose JA, et al. Global access to surgical care: a modelling study. Lancet Glob Health. 2015;3(6):e316-e323.
51) Shrime MG, Dare AJ, Alkire BC, O’Neill K, Meara JG. Catastrophic expenditure to pay for surgery worldwide: a modelling study. Lancet Glob Health. 2015;3(Suppl 2):S38-S44.
52) Institute of Medicine. Best care at lower cost: the path to continuously learning health care in America. Washington DC: National Academies Press; 2013.
53) Jaraczewski TJ, Abebe BM, Diehl T, Esayas T, Melaku W, Nigussie Y, et al. Implementation of a perioperative registry in Ethiopia to enhance surgical quality improvement. World J Surg. 2024;48(8):1829-1839.
54) Riley RD, Ensor J, Snell KIE, Debray TPA, Altman DG, Moons KGM, et al. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ. 2016;353:i3140.
55) Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373-1379.

Cite this article

Yao, S. K., Teti, L. S. F., Traoré, D., Kouadio, A., Kouassi, K. J. J., & Haidara, A. (2026). Measuring the Quality of Neurosurgical Care Through Intracranial Suppurations: A Twenty-Indicator Framework Tested on 150 Cases at Bouaké University Hospital. INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH, 5(10), 1046-1062. https://doi.org/10.58806/ijhmr.2026.v5i10n08